Vlad Coric - Net Worth and Insider Trading
Vlad Coric Net Worth
The estimated net worth of Vlad Coric is at least $48 Million dollars as of 2023-04-01. Vlad Coric is the CEO of Biohaven Ltd and owns about 2,544,614 shares of Biohaven Ltd (BHVN) stock worth over $35 Million. Vlad Coric is also the CEO of Biohaven Pharmaceutical Holding Co Ltd and owns about 934,130 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) stock worth over $13 Million. Details can be seen in Vlad Coric's Latest Holdings Summary section.
Transaction Summary of Vlad Coric
Vlad Coric Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Vlad Coric owns 5 companies in total, including Biohaven Pharmaceutical Holding Co Ltd (BHVN) , Social Capital Suvretta Holdings Corp I (DNAA) , and Akili Inc (AKLI) among others .
Click here to see the complete history of Vlad Coric’s form 4 insider trades.
Insider Ownership Summary of Vlad Coric
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BHVN | Biohaven Pharmaceutical Holding Co Ltd | 2017-05-03 | director & Chief Executive Officer |
| DNAA | Social Capital Suvretta Holdings Corp I | 2021-06-29 | director |
| AKLI | Akili Inc | 2021-06-29 | director |
| BHVN | Biohaven Ltd | 2022-10-03 | director & Chief Executive Officer |
| RVNC | Revance Therapeutics Inc | 2023-03-01 | director |
Vlad Coric Latest Holdings Summary
Vlad Coric currently owns a total of 2 stocks. Among these stocks, Vlad Coric owns 2,544,614 shares of Biohaven Ltd (BHVN) as of October 31, 2022, with a value of $35 Million and a weighting of 72.55%. Vlad Coric also owns 934,130 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) as of June 26, 2019, with a value of $13 Million and a weighting of 27.45%.
Latest Holdings of Vlad Coric
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BHVN | Biohaven Ltd | 2022-10-31 | 2,544,614 | 13.66 | 34,759,427 |
| BHVN | Biohaven Pharmaceutical Holding Co Ltd | 2019-06-26 | 934,130 | 14.08 | 13,152,550 |
Holding Weightings of Vlad Coric
Vlad Coric Form 4 Trading Tracker
According to the SEC Form 4 filings, Vlad Coric has made a total of 3 transactions in Biohaven Ltd (BHVN) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Biohaven Ltd is the acquisition of 25,800 shares on October 31, 2022, which cost Vlad Coric around $412,026.
According to the SEC Form 4 filings, Vlad Coric has made a total of 3 transactions in Biohaven Pharmaceutical Holding Co Ltd (BHVN) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in Biohaven Pharmaceutical Holding Co Ltd is the acquisition of 5,000 shares on June 26, 2019, which cost Vlad Coric around $201,100.
Insider Trading History of Vlad Coric
- 1
Vlad Coric Trading Performance
GuruFocus tracks the stock performance after each of Vlad Coric's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Vlad Coric is 18.27%. GuruFocus also compares Vlad Coric's trading performance to market benchmark return within the same time period. The performance of stocks bought by Vlad Coric within 3 months outperforms 4 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Vlad Coric's insider trading performs compared to the benchmark.
Performance of Vlad Coric
Average Relative Return
66.36%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Relative Return(%) | 2.5 | 18.27 | 35.13 | 66.36 | 53 | 50.75 |
| Relative Return to S&P 500(%) | -1.27 | 14.3 | 23.94 | 63.1 | 31.79 | 40.42 |
Vlad Coric Ownership Network
Ownership Network List of Vlad Coric
Ownership Network Relation of Vlad Coric
Vlad Coric Owned Company Details
What does Biohaven Pharmaceutical Holding Co Ltd do?
Biohaven Pharmaceutical Holding Co Ltd is a clinical-stage biopharmaceutical company. It has a portfolio of late-stage product candidates targeting neurological diseases, including rare disorders. The company product candidates are based on multiple mechanisms-calcitonin gene-related peptide receptor antagonists, glutamate modulators and myeloperoxidase inhibitor. Its pipeline products include BHV-3100, BHV5000, BHV5500, among others.
Who are the key executives at Biohaven Pharmaceutical Holding Co Ltd?
Vlad Coric is the director & Chief Executive Officer of Biohaven Pharmaceutical Holding Co Ltd. Other key executives at Biohaven Pharmaceutical Holding Co Ltd include Officer Matthew Buten , VP & Chief Accounting Officer George C. Clark , and Chief Medical Officer Elyse Stock .
Biohaven Pharmaceutical Holding Co Ltd (BHVN) Insider Trades Summary
Over the past 18 months, Vlad Coric made no insider transaction in Biohaven Pharmaceutical Holding Co Ltd (BHVN). Other recent insider transactions involving Biohaven Pharmaceutical Holding Co Ltd (BHVN) include a net sale of 15,490 shares made by George C. Clark , a net sale of 62,265 shares made by Declan Doogan , and a net purchase of 38,000 shares made by Gregory Bailey .
In summary, during the past 3 months, insiders sold 0 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 153,613 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) were sold and 43,000 shares were bought by its insiders, resulting in a net sale of 110,613 shares.
Biohaven Pharmaceutical Holding Co Ltd (BHVN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Biohaven Pharmaceutical Holding Co Ltd Insider Transactions
Vlad Coric Mailing Address
Above is the net worth, insider trading, and ownership report for Vlad Coric. You might contact Vlad Coric via mailing address: C/o Biohaven Pharmaceutical Holding Comp, 234 Church Street, New Haven Ct 06510.
